Cite
MLA Citation
Bengt C Fellström et al.. “Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial.” Lancet, vol. 389, no. 10084, 2017, pp. 2117–2127. http://access.bl.uk/ark:/81055/vdc_100046742378.0x000003